A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder

被引：5
|
作者：
Kao, Chester [1 ]
McNamara, Megan [1 ,2 ,3 ]
Alley, Chris [4 ]
Spector, Neil [1 ,2 ,3 ]
Jauhari, Shekeab [1 ]
Gupta, Rajan T. [5 ]
Zhang, Tian [1 ,2 ]
Zhu, Jason [1 ]
机构：
[1] Duke Univ, Dept Med, Durham, NC USA
[2] Duke Univ, Duke Canc Inst, Durham, NC USA
[3] Durham VA Med Ctr, Dept Hematol & Oncol, Durham, NC USA
[4] Duke Univ, Dept Pathol, Durham, NC 27706 USA
[5] Duke Univ, Dept Radiol, Durham, NC 27710 USA
来源：
CLINICAL GENITOURINARY CANCER | 2019年 / 17卷 / 03期
关键词：
Bladder cancer; Cisplatin ineligible; Immune checkpoint inhibitors; Metastatic bladder squamous cell carcinoma; PD-1; inhibitor; Psuedoprogression; IMMUNE-RELATED RESPONSE; RADICAL CYSTECTOMY; CISPLATIN; SURVIVAL; THERAPY; PSEUDOPROGRESSION; METHOTREXATE; VINBLASTINE; DOXORUBICIN; OUTCOMES;
D O I：
10.1016/j.clgc.2019.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E672 / E677
页数：6
相关论文
共 50 条
  • [41] Dermatologic complication of pembrolizumab as a predictor of complete response in the treatment of metastatic urothelial cell carcinoma: a case report
    Kao, Chien Chang
    Shau, Hua Yu
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 442 - 442
  • [42] Possible Pseudo-progression of Non-small Cell Lung Carcinoma in a Patient With Clinical Hyper-progression Associated With Trousseau Syndrome Who Was Treated With Pembrolizumab: A Case Report
    SHIONOYA, Y. O. S. U. K. E.
    HIROHASHI, Y. O. S. H. I. H. I. K. O.
    TAKAHASHI, H. A. R. U. K. A.
    HASHIMOTO, M. I. D. O. R. I.
    NISHIYAMA, K. A. O. R. U.
    TAKAKUWA, Y. A. S. U. N. A. R., I
    NAKATSUGAWA, M. U. N. E. H. I. D. E.
    KUBO, T. E. R. U. F. U. M., I
    KANASEKI, T. A. K. A. Y. U. K. I.
    TSUKAHARA, T. O. M. O. H. I. D. E.
    TORIGOE, T. O. S. H. I. H. I. K. O.
    ANTICANCER RESEARCH, 2021, 41 (07) : 3699 - 3706
  • [43] Afatinib in Combination with Pembrolizumab in Patients with Stage IIIB/IV Squamous Cell Carcinoma (SCC) of the Lung
    Riess, J.
    Bennouna, J.
    Paz-Ares, L.
    Chisamore, M.
    Lind, C. Lybeck
    Sadrolhefazi, B.
    Levy, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2401 - S2401
  • [44] COMPLETE RESPONSE TO VINFLUNINE IN A PATIENT WITH METASTATIC UROTHELIAL CARCINOMA OF THE BLADDER
    Cerullo, Carmine
    Fonte, Carla
    Lunghi, Alice
    Neri, Bruno
    ANTICANCER RESEARCH, 2014, 34 (05) : 2639 - 2640
  • [45] Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
    Domingo-Musibay, Evidio
    Murugan, Paari
    Giubellino, Alessio
    Sharma, Sandeep
    Steinberger, Daniel
    Yuan, Jianling
    Hunt, Matthew A.
    Lou, Emil
    Miller, Jeffrey S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [46] Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney
    Kamei, Jun
    Yokoyama, Hirotaka
    Niki, Toshiro
    Suda, Ryosuke
    Sugihara, Toru
    Fujisaki, Akira
    Ando, Satoshi
    Iwami, Daiki
    Fujimura, Tetsuya
    IJU CASE REPORTS, 2022, 5 (03) : 199 - 202
  • [47] Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report
    Chen, San-Chi
    Chao, Yee
    Yang, Muh-Hwa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (04): : 659 - 660
  • [48] Development of Merkel Cell Carcinoma and Squamous Cell Carcinoma During Treatment With Pembrolizumab for Metastatic Mucosal Melanoma
    Hajar, Tamar
    Hill, Emma E.
    Leitenberger, Justin J.
    DERMATOLOGIC SURGERY, 2020, 46 (11) : 1443 - 1445
  • [49] Pedal Presentation of Metastatic Invasive Squamous Cell Carcinoma of the Bladder
    Dux, Katherine E.
    Sage, Ronald A.
    Gocke, Sean P.
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2009, 99 (03) : 251 - 253
  • [50] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    MEDICINE, 2017, 96 (52)
12345